3/A

AMENDMENT NO. 1 TO OWNERSHIP DOCUMENT

Company: FENNEC PHARMACEUTICALS INC.
Filed: October 4, 2017
Period of Report: September 11, 2017
Accession Number: 0001213900-17-010282

View Document ↗ View on SEC.gov ↗